Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Tech|2026-09-23 at 19:31 UTC|Source: techcrunch.com
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.